CD8A and myeloid sarcoma: Finally, comparing patients with MS treated with aCD20 who did and did not generate anti-RBD IgG responses revealed differences in immune response coordination, with substantial reduction in vaccine-induced circulating TFH cell responses and reciprocal increases in CD8 T cell responses in those who lacked anti-RBD antibodies.